Stanford University scientists have identified a single protein, 15-PGDH, that drives the breakdown of cartilage as the human body ages. In a series of experiments, researchers demonstrated that blocking this protein in older mice allowed worn knee cartilage to thicken and restore itself. "Blocking it can restore worn joints in mice and human tissue," according to the study published on April 24. This breakthrough raises the prospect of a future where joint replacement surgery is no longer a physical necessity. However, the discovery is already being mapped onto the "Metabolic Divide." The study also found that semaglutide, the active ingredient in weight-loss drug Wegovy, protects joint cartilage by "reprogramming cartilage cell metabolism." This means that the future of mobility is being tied to high-priced pharmaceutical subscriptions. While the science offers hope for the millions suffering from arthritis, the reality is that access to these breakthroughs will likely be gated by the same corporate paywalls that currently restrict weight-loss drugs to the global elite. The restoration of the human body is becoming a luxury service rather than a public health right.